Dr Faiz Kermani has 15 years' experience in both academia and the pharmaceutical industry. He has worked in pharmaceutical R&D, pricing and reimbursement, marketing and medical education. Dr Kermani holds a PhD in Immunopharmacology from St. Thomas' Hospital, London, and a First Class Honours degree in Pharmacology with Toxicology from King's College, London. He has written extensively on international healthcare issues, and is on the editorial board of a number of publications, including Contract Services Europe (Advanstar Communications, UK), Contract Pharma (Rodman Publishing, USA) and Medical Science Liaison (MSL) Quarterly (MSL Institute LLC, USA). In March 2006, he was a delegate on the UK Government's Trade and Investment Biotech Scoping Mission to China and contributed to the subsequent report.
Dr Kermani is co-editor of the multiauthor book Patient Compliance: Sweetening the Pill (Gower Publishing, 2006), much of which forms the baseline for this expert review.
Dr Faiz Kermani has 15 years' experience in both academia and the pharmaceutical industry. He has worked in pharmaceutical R&D, pricing and reimbursement, marketing and medical education. Dr Kermani holds a PhD in Immunopharmacology from St. Thomas' Hospital, London, and a First Class Honours degree in Pharmacology with Toxicology from King's College, London. He has written extensively on international healthcare issues, and is on the editorial board of a number of publications, including Contract Services Europe (Advanstar Communications, UK), Contract Pharma (Rodman Publishing, USA) and Medical Science Liaison (MSL) Quarterly (MSL Institute LLC, USA). In March 2006, he was a delegate on the UK Government's Trade and Investment Biotech Scoping Mission to China and contributed to the subsequent report.
